Patients fulfilling minimal disease activity and remission criteria according to type of treatment (n = 141). Chi-squared or Fisher’s exact test were used, as appropriate. Except for p values, data are n (% of DMARD category).
| No DMARD, n = 42 | csDMARD, n = 53 | bDMARD, n = 18 | csDMARD and bDMARD, n = 28 | p | |
|---|---|---|---|---|---|
| MDA, n = 32, 1 missing (22.9) | 5/41 (12.2) | 14 (26.4) | 4 (22.2) | 9 (32.1) | 0.20 |
| DAS28-ESR < 2.4, n = 37 (26.2) | 9 (21.4) | 14 (26.4) | 6 (33.3) | 8 (28.6) | 0.79 |
| SDAI < 3.3, n = 30 (21.3) | 6 (14.3) | 12 (22.6) | 5 (27.8) | 7 (25.0) | 0.58 |
| DAPSA ≤ 4.0, n = 17 (12.1) | 4 (9.5) | 7 (13.2) | 3 (16.7) | 3 (10.7) | 0.85 |
| CPDAI ≤ 2, n = 13, 1 missing (9.3) | 3/41 (7.3) | 4 (7.5) | 3 (16.7) | 3 (10.7) | 0.63 |
| CPDAI-JED = 0, n = 11 (7.8) | 3 (7.1) | 3 (5.7) | 4 (22.2) | 1 (3.6) | 0.15 |
| PASDAS < 2.4, n = 11 (7.8) | 2 (4.8) | 6 (11.3) | 1 (5.6) | 2 (7.1) | 0.71 |
| Boolean’s, n = 8 (5.7) | 2 (4.8) | 3 (5.7) | 3 (16.7) | 0 (0) | 0.11 |
DMARD: disease-modifying antirheumatic drugs; csDMARD: conventional synthetic DMARD; bDMARD: biologic DMARD; MDA: minimal disease activity; DAS28-ESR: Disease Activity Score including 28-joint count with erythrocyte sedimentation rate; SDAI: Simplified Disease Activity Index; DAPSA: Disease Activity Index for Psoriatic Arthritis; CPDAI: Composite Psoriatic Disease Activity Index; CPDAI-JED: joint, entheses, and dactylitis domains of CPDAI; PASDAS: Psoriatic Arthritis Disease Activity Score; Boolean’s: Boolean’s remission criteria modified for psoriatic arthritis.